fashion -WSS

fashion

author：entertainment 2025-09-06 01:55:20 - browse：92

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Novo pauses ads for weight loss drug Wegovy amid demand

knowledge

hotspot

WSS

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

First Opinion Podcast: How to protect health care in times of war

Biden's order seeks to regulate AI risk without stifling innovation

Eli Lilly to pay $200M for Beam’s stake in gene

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Senate panel to vote on hospitals, PBMs, prisoner care

hotspot

fashion

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Affirmative action in medical school literally saved lives

How to fix the rural physician shortage in the U.S.

Guidelines to prevent youth baseball injuries need more muscle

Inside the rise of 'mukbang' eating videos

Jerome Adams on the need for new antivirals for Covid

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Malaria cases in Florida and Texas: Here’s what you need to know

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

focus

Biden's order seeks to regulate AI risk without stifling innovation

Biden administration plans revamp of organ transplant system

Readout Newsletter: New research from Sanofi, Regeneron, etc.

The FDA weighs the risks of candy

Traditional Chinese medicine benefits explored in new JAMA study

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

knowledge

knowledge

hotspot

Wikipedia